Espacio reservado para banners y logos institucionales

SABER UCV >  1) Investigación >  Artículos Publicados > 

> Selective Mastoparan inhibition of muscarinic activation of bovine tracheal smooth muscle
Please use this identifier to cite or link to this item: https://saber.ucv.ve/handle/10872/2804

Title: Selective Mastoparan inhibition of muscarinic activation of bovine tracheal smooth muscle
Authors: Hassan-Soto, Walid
Guerra de González, Lérida
González de Alfonzo, Ramona
Lippo de Becemberg, Itala
Alfonzo R., Marcelo J.
Keywords: Tracheal smooth muscle
carbachol
mastoparan
soluble guanylyl cyclase
Natriuretic Peptide Receptor-guanylyl cyclase
Issue Date: 2012
Publisher: AVFT Archivos Venezolanos de Farmacología y Terapéutica
Series/Report no.: Vol. 31;4
Abstract: Muscarinic activation of bovine tracheal smooth muscle (BTSM) leading to smooth muscle contraction involves the generation of two cGMP signals (20 and 60 s), being 20s peak associated with soluble (sGC) and the second (60s) to membrane-bound Natriuretic Peptide- receptor-Guanylylcyclases (NPR-GC). In this study, we showed that pre-incubation of isolated BTSM strips with mastoparan and superactive mastoparan (mastoparan 7) decreased significantly the muscarinic dependent contractile smooth muscle responses in dose-dependent and non-competitive manner. Moreover, mastoparan (50 nM) inhibited completely the BTSM-muscarinic contractile responses and affected dramatically the carbachol-dependent cGMP signals being the first cGMP signal inhibited in a 63 ± 5%, whereas the second signal disappeared. Mastoparan inhibition of muscarinic activation is specific since other spasmogens as serotonin and histamine fully contracted these BTSM strips under mastoparan treatment. Cyclic GMP levels were evaluated by exposing BTSM strips to activators of NO-sensitive sGC as Sodium Nitroprussiate (SNP) and Natriuretic Peptides as CNP-53 for membrane-bound NPR-GC. Thus, SNP and CNP increased in a binary way, in more than 20 fold cGMP levels at 30-40 s being both increments inhibited by mastoparan. Furthermore, the Gi/o-protein involvement on mastoparan inhibition of cGMP elevations induced by CNP and SNP is suggested by Pertussis toxin pre-treatment, which reversed mastoparan effects. These results indicate that muscarinic signal transduction cascades leading to airway smooth muscle contractions involved two different guanylyl cyclases being both regulated by mastoparan-sensitive G-proteins.
URI: http://hdl.handle.net/10872/2804
ISSN: 0798-0264
Appears in Collections:Artículos Publicados

Files in This Item:

File Description SizeFormat
selective_mastopan_inhbition.pdf758.67 kBAdobe PDFView/Open
View Statistics

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.